---
layout: minimal-medicine
nav_exclude: true
title: Mercaptopurine
---

# Mercaptopurine

**Generic Name:** Mercaptopurine

**Usage:**

Mercaptopurine is a type of antimetabolite chemotherapy drug used primarily to treat certain types of cancers and inflammatory bowel diseases.  Specifically, it's used in:

* **Acute lymphoblastic leukemia (ALL):** Often used in combination with other chemotherapy drugs as part of an induction, consolidation, or maintenance therapy regimen.
* **Acute myelogenous leukemia (AML):**  Sometimes used in combination therapy for certain types of AML.
* **Chronic myelogenous leukemia (CML):**  May be used in combination with other therapies, although it's less common than other agents.
* **Inflammatory bowel disease (IBD), specifically Crohn's disease and ulcerative colitis:** Used to reduce inflammation and maintain remission in patients who haven't responded to other treatments.


**Side Effects:**

Mercaptopurine can cause a wide range of side effects, some mild and others severe.  The severity and likelihood depend on the dosage and individual patient factors.  Common side effects include:

* **Nausea and vomiting:**  Often manageable with antiemetic medications.
* **Diarrhea:**  Can be mild to severe.
* **Loss of appetite:** Leading to weight loss.
* **Fatigue and weakness:**  Commonly experienced during treatment.
* **Hair loss (alopecia):**  Can be temporary or permanent.
* **Mouth sores (stomatitis):**  Can make eating difficult.
* **Low white blood cell count (leukopenia):** Increases risk of infection.
* **Low red blood cell count (anemia):** Leads to fatigue and weakness.
* **Low platelet count (thrombocytopenia):** Increases risk of bleeding.
* **Liver damage (hepatotoxicity):**  A serious potential side effect requiring close monitoring of liver function tests.
* **Pancreatitis:** Inflammation of the pancreas, a serious and potentially life-threatening condition.
* **Increased risk of infections:** Due to the immunosuppressive effects of the drug.


**How it Works:**

Mercaptopurine is a purine analog.  It interferes with the synthesis of DNA and RNA, essential components of cells.  By disrupting these processes, it inhibits the growth and proliferation of rapidly dividing cells, including cancer cells and immune cells involved in the inflammatory process in IBD.  The body converts mercaptopurine into its active metabolite, thioguanine nucleotides (TGNs), which then exert their cytotoxic effects.  The specific mechanism involves inhibiting key enzymes involved in nucleotide metabolism.


**FAQs:**

* **How is mercaptopurine administered?** It's usually taken orally as a tablet.
* **How long is the treatment course?** This varies greatly depending on the condition being treated and the patient's response. It can range from several weeks to several years.
* **What are the blood tests needed to monitor for side effects?** Regular blood tests, including complete blood counts (CBC) and liver function tests (LFTs), are essential to monitor for

**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.